Salvatore Thomas Butera Volitionrx LTD (VNRX) insider trading activity

Salvatore Thomas Butera is CEO, Volition Veterinary of VOLITIONRX LTD. Currently has a direct ownership of 276,719 shares of VNRX, which is worth approximately $232,443. The most recent transaction as insider was on Oct 04, 2024, when has been sold 5,834 shares (Common Stock) at a price of $0.88 per share, resulting in proceeds of $5,133. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 277K

9.81% 3M change

248.73% 12M change

Total Value Held $232,443

Salvatore Thomas Butera Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 04 2024	SELL Payment of exercise price or tax liability	$5,133 $0.88 p/Share	5,834 Reduced 2.06%	276,719 Common Stock
Sep 28 2024	SELL Payment of exercise price or tax liability	$3,033 $0.58 p/Share	5,230 Reduced 1.82%	282,553 Common Stock
Sep 01 2024	BUY Grant, award, or other acquisition	-	35,783 Added 11.06%	287,783 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	21,250 Added 7.78%	252,000 Common Stock
Jun 01 2024	BUY Grant, award, or other acquisition	-	31,256 Added 11.93%	230,750 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$13,488 $0.87 p/Share	15,504 Reduced 7.21%	199,494 Common Stock
Jan 24 2024	BUY Grant, award, or other acquisition	-	36,125 Added 14.39%	214,998 Common Stock
Dec 18 2023	BUY Open market or private purchase	$8,300 $0.83 p/Share	10,000 Added 9.14%	99,350 Common Stock
Dec 15 2023	BUY Open market or private purchase	$7,700 $0.77 p/Share	10,000 Added 10.07%	89,350 Common Stock
Nov 16 2023	BUY Open market or private purchase	$8,100 $0.81 p/Share	10,000 Added 11.19%	79,350 Common Stock
Oct 04 2023	SELL Payment of exercise price or tax liability	$3,967 $0.68 p/Share	5,834 Reduced 3.16%	178,873 Common Stock
Aug 16 2023	BUY Open market or private purchase	$9,680 $1.21 p/Share	8,000 Added 10.34%	69,350 Common Stock
Jul 05 2023	BUY Grant, award, or other acquisition	-	28,800 Added 13.49%	184,707 Common Stock
Jun 02 2023	BUY Open market or private purchase	$15,900 $1.59 p/Share	10,000 Added 14.02%	61,350 Common Stock
May 01 2023	SELL Payment of exercise price or tax liability	$23,869 $1.67 p/Share	14,293 Reduced 8.4%	155,907 Common Stock
Jan 12 2023	BUY Grant, award, or other acquisition	-	24,000 Added 12.36%	170,200 Common Stock
Dec 19 2022	BUY Open market or private purchase	$11,350 $2.27 p/Share	5,000 Added 8.87%	51,350 Common Stock
Dec 12 2022	BUY Open market or private purchase	$9,091 $2.09 p/Share	4,350 Added 8.58%	46,350 Common Stock
Nov 28 2022	BUY Open market or private purchase	$11,050 $2.21 p/Share	5,000 Added 10.64%	42,000 Common Stock
Oct 13 2022	BUY Grant, award, or other acquisition	-	11,200 Added 7.12%	146,200 Common Stock
Aug 23 2022	BUY Open market or private purchase	$8,000 $1.6 p/Share	5,000 Added 2.94%	165,000 Common Stock
Aug 22 2022	BUY Open market or private purchase	$8,200 $1.64 p/Share	5,000 Added 3.03%	160,000 Common Stock
Jun 16 2022	BUY Open market or private purchase	$20,500 $2.05 p/Share	10,000 Added 6.06%	155,000 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$41,850 $2.79 p/Share	15,000 Reduced 9.38%	145,000 Common Stock
Nov 16 2021	BUY Open market or private purchase	$40,200 $4.02 p/Share	10,000 Added 50.0%	10,000 Common Stock

STB

Salvatore Thomas Butera

CEO, Volition Veterinary

Henderson, NV

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNRX shares.

Notify only if

Value

Insider Trading

Get notified when an Volitionrx LTD insider buys or sells VNRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VOLITIONRX LTD

Track Activities on VNRX

Account